In conclusion, the present results suggest that fisetin‐blocked NLRP3 inflammasome activation via promoting mitophagy in CMECs may suppress the secretion of IL‐1β into the CNS, reduce neuroinflammation, and contribute to the amelioration of cognitive impairment. The gene discussed is NLRP3; the disease is Cognitive impairment.